You are invited to join a webinar hosted by the Health Intervention Technology Assessment Program (HITAP, Thailand) that will feature a guest lecture by Assistant Professor Wenjia Chen from the Saw Swee Hock School of Public Health, National University of Singapore (SSHSPH NUS). She will be discussi

Welcome to HTAsiaLink Newsletter, Volume 21!  This year, our network has continued to grow, work together, and share knowledge. From research exchanges and capacity-building activities to policy discussions, our members have shown what can be achieved when we move forward together.  The theme

Ryan Jonathan Sitanggang is an International Cooperation Officer (ICO) at the International Unit of the HITAP Foundation. He works on strengthening HTA networks and systems across Asia through initiatives such as the Asia HTA Registry, the HTAsiaLink Strategic Plan, and regional capacity-building. His role includes managing partnerships, coordinati

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

การจัดกระบวนการพัฒนาชุดสิทธิประโยชน์แบบครบวงจร ภายใต้ระบบหลักประกันสุขภาพแห่งชาติ เป็นการดำเนินงานตามที่ได้รับมอบหมายจ

201-369-2555HITA,HITAP,HTA,method guidelines,การประเมินความคุ้มค่าด้านสุขภาพ

To execute planned activities and to seize opportunities to support partners in India build capacity in HTA and in implementation of UHC. HITAP will use the remaining funds to support a Post-Doctoral Fellow from PGIMER. Further, depending on the demand, HITAP may support its academic partners, CMC Vellore and JIPMER, the latter being a HTA Resource

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.

Building technical capacity as well as providing technical support to conduct HTA related study and institutionalise HTA process in Bhutan.